- Sort by Default Order
Ultra-High Sensitivity MX-ICP Oncology Testing
Enabling Precision Treatment for Oncology Patients
Multiplexed ICE COLD-PCR (MX-ICP), Transgenomic’s exclusive technology, amplifies the limited amount of mutant DNA which may be present in plasma to enable accurate and sensitive liquid biopsies. This means Oncologists can be more confident in their treatment choice for patients with non-small cell lung cancer (NSCLC) and colorectal cancer (CRC).
Key features of Multiplexed ICE COLD-PCR:
✔Amplifies sensitivity – up to 500-fold greater than Next-Generation Sequencing (NGS).
✔Allows precision identification of mutations – down to 0.01% – using mutation enrichment technology.
✔Enables non-invasive diagnostics using liquid samples with only 10ml of blood required from already compromised cancer patients.
✔Enables precision treatment by detecting all mutations on the allele in focus and an additional 50-base pairs in the region.
✔Works on most sample types and testing platforms.